The Ontario Institute for Cancer Research (OICR) has announced new funds to further enhance imaging research in Ontario and to develop improved imaging tools for more personalized diagnosis and treatment of cancer patients worldwide.
Canadians are waiting nearly 2-1/2 years for government bureaucracies to approve new prescription drugs for public use, says a report from public policy think-tank the Fraser Institute.